Johnson & Johnson Stock Rises 53% After Beating Earnings Expectations
Johnson & Johnson (ISIN US4781601046) stock has performed well after its second-quarter earnings report for 2026 exceeded expectations and guidance was raised. The company reported mid-single-digit operational sales growth, improving adjusted earnings per share, and strong free cash flow generation.
The Q2 2026 financial highlights showed a 5.6% increase in operational sales growth compared to the prior-year period, driven by broad-based strength across its businesses. Adjusted net earnings came in at $7.08 billion, an increase from $6.70 billion in Q2 2025, which corresponds to growth of 5.7%. The company also raised its full-year guidance, signaling confidence in its earnings power and cash generation for the remainder of 2026.
Johnson & Johnson's free cash flow is expected to trend toward $21 billion for the year, with a strong balance sheet that supports ongoing dividend increases and a path toward crossing $100 billion in annual revenue. The company has increased its quarterly dividend from $0.90 per share in 2018 to $1.34 per share in 2026, reflecting an extended streak of annual raises.